Zoetis Inc (ZTS)
171.75
+5.80
(+3.50%)
USD |
NYSE |
May 07, 13:31
Zoetis 1 Year Total Returns (Daily): -10.03% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | -10.03% |
| May 03, 2024 | -5.09% |
| May 02, 2024 | -4.55% |
| May 01, 2024 | -10.87% |
| April 30, 2024 | -8.53% |
| April 29, 2024 | -8.27% |
| April 26, 2024 | -7.51% |
| April 25, 2024 | -10.50% |
| April 24, 2024 | -13.61% |
| April 23, 2024 | -14.63% |
| April 22, 2024 | -16.92% |
| April 19, 2024 | -15.28% |
| April 18, 2024 | -11.19% |
| April 17, 2024 | -12.20% |
| April 16, 2024 | -11.57% |
| April 15, 2024 | -13.45% |
| April 12, 2024 | -11.73% |
| April 11, 2024 | -4.10% |
| April 10, 2024 | -3.63% |
| April 09, 2024 | -0.17% |
| April 08, 2024 | -1.04% |
| April 05, 2024 | -0.18% |
| April 04, 2024 | -0.03% |
| April 03, 2024 | -1.92% |
| April 02, 2024 | 0.04% |
| Date | Value |
|---|---|
| April 01, 2024 | 1.25% |
| March 28, 2024 | 3.45% |
| March 27, 2024 | 2.61% |
| March 26, 2024 | 1.82% |
| March 25, 2024 | 3.13% |
| March 22, 2024 | 5.60% |
| March 21, 2024 | 2.16% |
| March 20, 2024 | 4.05% |
| March 19, 2024 | 6.11% |
| March 18, 2024 | 4.72% |
| March 15, 2024 | 6.45% |
| March 14, 2024 | 6.62% |
| March 13, 2024 | 8.82% |
| March 12, 2024 | 13.28% |
| March 11, 2024 | 14.62% |
| March 08, 2024 | 8.99% |
| March 07, 2024 | 9.65% |
| March 06, 2024 | 9.14% |
| March 05, 2024 | 9.58% |
| March 04, 2024 | 11.14% |
| March 01, 2024 | 14.90% |
| February 29, 2024 | 19.83% |
| February 28, 2024 | 20.80% |
| February 27, 2024 | 21.35% |
| February 26, 2024 | 19.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-40.68%
Minimum
Dec 28 2022
69.37%
Maximum
Mar 23 2021
17.81%
Average
23.17%
Median
Jan 24 2022
1 Year Total Returns (Daily) Benchmarks
| Biogen Inc | -30.39% |
| Pfizer Inc | -23.01% |
| Eli Lilly and Co | 80.70% |
| Bristol-Myers Squibb Co | -32.81% |
| Amgen Inc | 30.91% |